| Home > Zentren > Zentrum für Operative Medizin > Klinik und Poliklinik für Urologie > Publikationen 2006

Publikationen 2006


29  Steuber T, Vickers AJ, Serio AM, Vaisanen V, Haese A, Pettersson K, Eastham JA, 
Scardino PT, Huland H, Lilja H. 
Comparison of Free and Total Forms of Serum Human Kallikrein 2 and Prostate-Specific 
Antigen for Prediction of Locally Advanced and Recurrent Prostate Cancer.
Clin Chem. 2006 Dec 21

28  Gallina A, Jeldres C, Chun FK, Shariat SF, Briganti A, Walz J, Roehrborn CG, 
Saad F, Huland H, Graefen M, Montorsi F, Karakiewicz PI. 
Prediction of Pathological Stage is Inaccurate in Men with PSA Values above 20ng/mL.
Eur Urol. 2006 Dec 11

27  Chun FK, Briganti A, Antebi E, Graefen M, Currlin E, Steuber T, Schlomm T, Walz J,
Haese A, Friedrich MG, Ahyai SA, Eichelberg C, Salomon G, Gallina A, Erbersdobler A, 
Perrotte P, Heinzer H, Huland H, Karakiewicz PI. 
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy 
in European patients.
BJU Int. 2006 Dec;98(6):1204-9

26  Steuber T, Chun FK, Erbersdobler A, Briganti A, Haese A, Graefen M, Schlomm T, 
Valiquette L, Huland H, Karakiewicz PI. 
Development and internal validation of preoperative transition zone prostate cancer nomogram.
Urology. 2006 Dec;68(6):1295-300

25  Chun FK, Briganti A, Graefen M, Erbersdobler A, Walz J, Schlomm T, Meschke M,
Haese A, Valiquette L, Huland H, Karakiewicz PI. 
Body mass index does not improve the ability to predict biochemical recurrence
after radical prostatectomy.
Eur J Cancer. 2006 Nov 30

24   Chun FK, Karakiewicz PI, Briganti A, Gallina A, Kattan MW, Montorsi F, Huland H, Graefen M. 
Prostate cancer nomograms: an update.
Eur Urol. 2006 Nov;50(5):914-26; discussion 926 

23  Chun FK, Briganti A, Graefen M, Montorsi F, Porter C, Scattoni V, Gallina A, Walz J, Haese A, 
Steuber T,  Erbersdobler A, Schlomm T, Ahyai SA, Currlin E, Valiquette L, Heinzer H, Rigatti P, Huland H, Karakiewicz PI. 
Development and External Validation of an Extended 10-Core Biopsy Nomogram.
Eur Urol. 2006 Sep 11

22  Chun FK, Muller I, Lange I, Friedrich MG, Erbersdobler A, Karakiewicz PI, Graefen M, Pantel K, 
Huland H, Schwarzenbach H. 
Circulating tumour-associated plasma DNA represents an independent and informative predictor
 of prostate cancer.
BJU Int. 2006 Sep;98(3):544-8. 

21  Walz J, Graefen M, Chun FK, Erbersdobler A, Haese A, Steuber T, Schlomm T, Huland H, Karakiewicz PI. 
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
Eur Urol. 2006 Sep;50(3):498-505. 

20  Shariat SF, Marberger MJ, Lotan Y, Sanchez-Carbayo M, Zippe C, Ludecke G, Boman H, Sawczuk I, Friedrich MG, 
Casella R, Mian C, Eissa S, Akaza H, Serretta
V, Huland H, Hedelin H, Raina R, Miyanaga N, Sagalowsky AI, Roehrborn CG, Karakiewicz PI. 
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.
J Urol. 2006 Sep;176(3):919-26

19  Huland H. 
The case against extended lymph-node dissection for prostate cancer.
Nat Clin Pract Urol. 2006 Sep;3(9):456-7. Review.

18:  Atzpodien J, Kirchner H, Rebmann U, Soder M, Gertenbach U, Siebels M, Roigas J, Raschke R, Salm S, 
Schwindl B, Muller SC, Hauser S, Leiber C, Huland
E, Heinzer H, Siemer S, Metzner B, Heynemann H, Fornara P, Reitz M. 
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
Br J Cancer. 2006 Aug 21;95(4):463-9.

17  Tilki D, Irmak S, Oliveira-Ferrer L, Hauschild J, Miethe K, Atakaya H, Hammerer P, Friedrich MG, Schuch G, Galalae R, Stief CG, Kilic E, Huland H,
Ergun S. 
CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer.
Oncogene. 2006 Aug 17;25(36):4965-74

16  Chun FK, Graefen M, Briganti A, Gallina A, Hopp J, Kattan MW, Huland H, Karakiewicz PI. 
Initial Biopsy Outcome Prediction-Head-to-Head Comparison of a Logistic Regression-Based Nomogram versus 
Artificial Neural Network.
Eur Urol. 2006 Aug 4

15 Chun FK, Briganti A, Shariat SF, Graefen M, Montorsi F, Erbersdobler A, Steuber T, Salonia A, Currlin E, 
Scattoni V, Friedrich MG, Schlomm T, Haese A,
Michl U, Colombo R, Heinzer H, Valiquette L, Rigatti P, Roehrborn CG, Huland H, Karakiewicz PI. 
Significant upgrading affects a third of men diagnosed with prostate cancer:
predictive nomogram and internal validation.
BJU Int. 2006 Aug;98(2):329-34. 

14  Chun FK, Graefen M, Zacharias M, Haese A, Steuber T, Schlomm T, Walz J, Karakiewicz PI, Huland H. 
Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
World J Urol. 2006 Aug;24(3):273-80

13  Chun FK, Briganti A, Jeldres C, Erbersdobler A, Schlomm T, Steuber T, Gallina A, Walz J, Perrotte P, 
Huland H, Graefen M, Karakiewicz PI. 
Zonal Origin of Localized Prostate Cancer Does not Affect the Rate of Biochemical Recurrence after Radical Prostatectomy.
Eur Urol. 2006 Jul 28

12  Michl UH, Friedrich MG, Graefen M, Haese A, Heinzer H, Huland H. 
Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy.
J Urol. 2006 Jul;176(1):227-31. 

11  Eichelberg C, Erbersdobler A, Haese A, Schlomm T, Chun FK, Currlin E, Walz J, Steuber T, Graefen M, Huland H. 
Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing 
scheduled radical prostatectomy.
Eur Urol. 2006 Jun;49(6):1011-6

10  Karakiewicz PI, Benayoun S, Zippe C, Ludecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, 
Friedrich MG, Eissa S, Akaza H, Huland H, Hedelin H, Rupesh
R, Miyanaga N, Sagalowsky AI, Marberger MJ, Shariat SF. 
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell 
carcinoma of the bladder.
BJU Int. 2006 May;97(5):997-1001

9  Piironen T, Haese A, Huland H, Steuber T, Christensen IJ, Brunner N, Dano K, Hoyer-Hansen G, Lilja H. 
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of 
cleaved forms of urokinase receptor in serum.
Clin Chem. 2006 May;52(5):838-44.

8  Chun FK, Steuber T, Erbersdobler A, Currlin E, Walz J, Schlomm T, Haese A, Heinzer H, McCormack M, 
Huland H, Graefen M, Karakiewicz PI. 
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum 
upgrading between biopsy and radical prostatectomy pathology.
Eur Urol. 2006 May;49(5):820-6.

7  Hautmann S, Chun KH, Currlin E, Braun P, Huland H, Juenemann KP. 
Refluxing chimney versus nonrefluxing LeDuc ureteroileal anastomosis for orthotopic ileal neobladder: 
a comparative analysis for patients with bladder cancer.
J Urol. 2006 Apr;175(4):1389-93

6  Steuber T, Vickers AJ, Haese A, Becker C, Pettersson K, Chun FK, Kattan MW, Eastham JA, Scardino PT,
 Huland H, Lilja H. 
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement 
contributed by human glandular kallikrein 2 (hK2) and
free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
Int J Cancer. 2006 Mar 1;118(5):1234-40. 

5  Steuber T, Graefen M, Haese A, Erbersdobler A, Chun FK, Schlom T, Perrotte P, Huland H, Karakiewicz PI. 
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
J Urol. 2006 Mar;175(3 Pt 1):939-44

4  Steuber T, Erbersdobler A, Graefen M, Haese A, Huland H, Karakiewicz PI. 
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical
 recurrence after radical prostatectomy.
Cancer. 2006 Feb 15;106(4):775-82. 

3:  Chun FK, Briganti A, Lebeau T, Fradet V, Steuber T, Walz J, Schlomm T, Eichelberg C, Haese A, Erbersdobler A, 
McCormack M, Perrotte P, Graefen M, Huland H, Karakiewicz PI. 
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.
Eur Urol. 2006 Feb;49(2):273-8

2:  Friedrich MG, Friedrich E, Graefen M, Heinzer H, Michl U, Huland H, Noldus J. 
Success rates of two-layer, microsurgical vasovasostomy. Results from a patient questionnaire and 
comparison with one-layer technique]
Aktuelle Urol. 2006 Jan;37(1):58-63

1:  Graefen M, Walz J, Huland H. 
Open retropubic nerve-sparing radical prostatectomy.
Eur Urol. 2006 Jan;49(1):38-48

Hauptnavigation:

Publikationen 2006

Huland H, Schwarzenbach H. Circulating tumour-associated plasma DNA represents an independent and informative predictor

Artificial Neural Network.Eur Urol. 2006 Aug 415 Chun FK, Briganti A, Shariat SF, Graefen M, Montorsi F, Erbersdobler A, Steuber T, Salonia A, Currlin E,

scheduled radical prostatectomy.Eur Urol. 2006 Jun;49(6):1011-610 Karakiewicz PI, Benayoun S, Zippe C, Ludecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C,

Friedrich MG, Eissa S, Akaza H, Huland H, Hedelin H, RupeshR, Miyanaga N, Sagalowsky AI, Marberger MJ, Shariat SF. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell

carcinoma of the bladder.BJU Int. 2006 May;97(5):997-10019 Piironen T, Haese A, Huland H, Steuber T, Christensen IJ, Brunner N, Dano K, Hoyer-Hansen G, Lilja H. Enhanced discrimination of benign from malignant prostatic disease by selective measurements of

cleaved forms of urokinase receptor in serum.Clin Chem. 2006 May;52(5):838-44.8 Chun FK, Steuber T, Erbersdobler A, Currlin E, Walz J, Schlomm T, Haese A, Heinzer H, McCormack M,

Huland H, Graefen M, Karakiewicz PI. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum

upgrading between biopsy and radical prostatectomy pathology.Eur Urol. 2006 May;49(5):820-6.7 Hautmann S, Chun KH, Currlin E, Braun P, Huland H, Juenemann KP. Refluxing chimney versus nonrefluxing LeDuc ureteroileal anastomosis for orthotopic ileal neobladder:

a comparative analysis for patients with bladder cancer.J Urol. 2006 Apr;175(4):1389-936 Steuber T, Vickers AJ, Haese A, Becker C, Pettersson K, Chun FK, Kattan MW, Eastham JA, Scardino PT,

Huland H, Lilja H. Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement

recurrence after radical prostatectomy.Cancer. 2006 Feb 15;106(4):775-82. 3: Chun FK, Briganti A, Lebeau T, Fradet V, Steuber T, Walz J, Schlomm T, Eichelberg C, Haese A, Erbersdobler A,

comparison with one-layer technique]Aktuelle Urol. 2006 Jan;37(1):58-631: Graefen M, Walz J, Huland H. Open retropubic nerve-sparing radical prostatectomy.Eur Urol. 2006 Jan;49(1):38-48

Huland H, Schwarzenbach H.
Circulating tumour-associated plasma DNA represents an independent and informative predictor

Artificial Neural Network.
Eur Urol. 2006 Aug 4

15 Chun FK, Briganti A, Shariat SF, Graefen M, Montorsi F, Erbersdobler A, Steuber T, Salonia A, Currlin E,

scheduled radical prostatectomy.
Eur Urol. 2006 Jun;49(6):1011-6

10 Karakiewicz PI, Benayoun S, Zippe C, Ludecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C,

Friedrich MG, Eissa S, Akaza H, Huland H, Hedelin H, Rupesh
R, Miyanaga N, Sagalowsky AI, Marberger MJ, Shariat SF.
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell

carcinoma of the bladder.
BJU Int. 2006 May;97(5):997-1001

9 Piironen T, Haese A, Huland H, Steuber T, Christensen IJ, Brunner N, Dano K, Hoyer-Hansen G, Lilja H.
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of

cleaved forms of urokinase receptor in serum.
Clin Chem. 2006 May;52(5):838-44.

8 Chun FK, Steuber T, Erbersdobler A, Currlin E, Walz J, Schlomm T, Haese A, Heinzer H, McCormack M,

Huland H, Graefen M, Karakiewicz PI.
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum

upgrading between biopsy and radical prostatectomy pathology.
Eur Urol. 2006 May;49(5):820-6.

7 Hautmann S, Chun KH, Currlin E, Braun P, Huland H, Juenemann KP.
Refluxing chimney versus nonrefluxing LeDuc ureteroileal anastomosis for orthotopic ileal neobladder:

a comparative analysis for patients with bladder cancer.
J Urol. 2006 Apr;175(4):1389-93

6 Steuber T, Vickers AJ, Haese A, Becker C, Pettersson K, Chun FK, Kattan MW, Eastham JA, Scardino PT,

Huland H, Lilja H.
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement

recurrence after radical prostatectomy.
Cancer. 2006 Feb 15;106(4):775-82.

3: Chun FK, Briganti A, Lebeau T, Fradet V, Steuber T, Walz J, Schlomm T, Eichelberg C, Haese A, Erbersdobler A,

comparison with one-layer technique]
Aktuelle Urol. 2006 Jan;37(1):58-63

1: Graefen M, Walz J, Huland H.
Open retropubic nerve-sparing radical prostatectomy.
Eur Urol. 2006 Jan;49(1):38-48